Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Crinetics Pharmaceuticals (CRNX) Asset Utilization Ratio (2018 - 2025)

Crinetics Pharmaceuticals has reported Asset Utilization Ratio over the past 8 years, most recently at 0.01 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 656.56% year-over-year to 0.01; the TTM value through Dec 2025 reached 0.01, up 656.56%, while the annual FY2025 figure was 0.01, 498.72% up from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.01 at Crinetics Pharmaceuticals, up from 0.0 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 0.02 in Q2 2023 and troughed at 0.0 in Q1 2025.
  • A 5-year average of 0.01 and a median of 0.01 in 2023 define the central range for Asset Utilization Ratio.
  • Biggest five-year swings in Asset Utilization Ratio: soared 939.79% in 2021 and later crashed 90.91% in 2024.
  • Year by year, Asset Utilization Ratio stood at 0.0 in 2021, then soared by 234.09% to 0.01 in 2022, then plummeted by 51.1% to 0.01 in 2023, then plummeted by 86.06% to 0.0 in 2024, then soared by 656.56% to 0.01 in 2025.
  • Business Quant data shows Asset Utilization Ratio for CRNX at 0.01 in Q4 2025, 0.0 in Q3 2025, and 0.0 in Q2 2025.